Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,360.00
Bid: 12,328.00
Ask: 12,332.00
Change: -4.00 (-0.03%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,256.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK sends first of 100 million promised vaccine doses to poorer nations

Wed, 28th Jul 2021 16:35

(Alliance News) - The first batch of excess coronavirus vaccines from Britain will be shipped off to "vulnerable" nations and Commonwealth allies this week, the UK Foreign Secretary has announced.

Leaders of the major industrialised nations at the G7 summit in Cornwall pledged more than one billion doses of Covid-19 vaccine – 870 million jabs shared directly and the rest through funding to the Covax initiative – to poorer countries.

Prime Minister Boris Johnson confirmed the UK's contribution to the one billion dose pledge is another 100 million vaccines from now to next June, with Dominic Raab announcing on Wednesday that the first shipment of nine million spare Oxford-AstraZeneca PLC will be made this week.

And in a message to western countries who have unused stockpiles of AstraZeneca jabs, Raab stressed that bodies ranging from the World Health Organisation to the European Medicines Agency had approved the British-designed vaccine as safe, arguing it was "crucially important" for all nations to vaccinate their populations.

It comes as parts of Australia have been forced to go back into lockdown despite the UK ally having three million unboxed doses of the AstraZeneca inoculation stored, according to reports.

Fears about the Oxford jab's side effects, including an increased risk of blood clots, have seen it shunned in some wealthy countries.

The Foreign Secretary visited an AstraZeneca manufacturing site in Oxford on Wednesday to announce that the first despatch of excess UK doses will be making their way to poorer nations this week – with five million to be distributed via the WHO's Covax scheme and another four million bilaterally.

Speaking to the PA news agency after the visit, the Cabinet minister said: "We succeeded in double-vaccinating 70% of the adult population, the UK economy is bouncing back but we know we're not going to be safe in the UK until everyone is safe.

"That is why we have been leading the (international) vaccine rollout to give enough doses to get the world vaccinated by the middle of next year, rather than the current trajectory, which is the end of 2024."

Raab said the UK was delivering on its G7 pledge of sending 100 million surplus vaccines to the "poorest and most vulnerable countries around the world" before the middle of 2022.

"The first nine million doses will be going on Friday to countries from vulnerable countries in the Indo-Pacific, such as Laos, Cambodia, key partners like Indonesia, right the way through the Commonwealth countries from Kenya to Jamaica," the Cabinet minister added.

"I think what it shows, as well as the domestic rollout and the importance of coming out of the lockdowns in the UK, is that global Britain is also a lifesaving force for good in the world."

Indonesia will receive 600,000 doses of those being handed out bilaterally, 300,000 will be sent to Jamaica and 817,000 are to be transported to Kenya, among other countries, the Foreign Office said.

Raab, who is also First Secretary of State, joined the prime minister and fellow Cabinet colleague Therese Coffey in refusing to repeat Michael Gove's assertion that it was "selfish" to refuse a vaccine.

The Chancellor of the Duchy of Lancaster's comment comes as the government prepares to make being double-jabbed a condition of entry to nightclubs in September in a bid to increase the number of young people coming forward for inoculation.

Asked what he made of Gove's remark, Raab told PA: "Look, I think people should get vaccinated for their own self-interest because it is far safer to do so, and I would encourage everyone to do so."

Professor Sir John Bell said the UK's decision to send unneeded Covid-19 vaccines to developing nations was "long overdue" and would help guard against new variants of the virus forming.

The Regius Professor of Medicine at Oxford University told BBC Radio 4's World At One programme: "I think it is a bit self-indulgent, to be honest, of western countries fretting about these kinds of issues (what rights to afford the fully vaccinated) when the vast majority of the globe remains completely unvaccinated, with massive levels of viral replication sweeping through the population.

"If you want variants, you've got the perfect storm for that, and it is not in Watford – it is in Zimbabwe and Rwanda and South Africa."

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.